CD8A and neoplasm: In addition to the reactivation of tumour suppressor genes, DNMTIs enhance tumour immunogenicity through the upregulation of major histocompatibility complex (MHC) class I, leading to the recruitment of macrophages, natural killer (NK) cells and CD8+ T cells that secrete a variety of chemotactic and cytotoxic cytokines [12].